We demonstrate that the cauliflower mosaic virus (CaMV) gene VI product can transactivate the expression of a reporter gene in bakers' yeast, Saccharomyces cerevisiae. The gene Vlcoding sequence was placed under the control of the galactose-inducible promoter GALI, which is present in the yeast shuttle vector pYES2, to create plasmid JS169. We also created a chloramphenicol acetyltransferase (CAT) reporter plasmid, JS161, by inserting the CAT reporter gene in-frame into CaMV gene II and subsequently cloning the entire CaMV genome into the yeast vector pRS314. When JS161 was transformed into yeast and subsequently assayed for CAT activity, only a very low level of CAT activity was detected in cellular extracts. To investigate whether the CaMV gene VI product would mediate an increase in CAT activity, we cotransformed yeast with JS169 and JS161. Upon induction with galactose, we found that CAT activity in yeast transformed with JS161 and JS169 was about 19 times higher than the level in the transformants that contained only JS161. CAT activity was dependent on the presence of the gene VI protein, because essentially no CAT activity was detected in yeast cells grown in the presence of glucose, which represses expression from the GAL) promoter. RNase protection assays showed that the gene VI product had no effect on transcription from the 35S RNA promoter, demonstrating that regulation was occurring at the translation level. This yeast system will prove useful for understanding how the gene VI product of CaMV mediates the translation of genes present on a eukaryotic polycistronic mRNA.Cauliflower mosaic virus (CaMV) is a plant pararetrovirus that has a unique strategy for the expression of its six genes. Two RNAs that have sizes of 19S and 35S are transcribed from the circular double-stranded DNA template (1). The monocistronic 19S RNA is responsible for the expression of the CaMV gene VI product, a protein that has been described as a translational transactivator (2). The 35S RNA is a terminally redundant RNA that has dual roles in replication and expression. It serves as a replication intermediate during reverse transcription of the viral genome (1). In addition, it is a polycistronic mRNA that contains a 600-nucleotide leader sequence followed by six closely spaced genes, including gene VI (1). The 35S RNA leader sequence itself is extremely complex. It contains seven to eight small open reading frames, depending on the strain, that vary in size from 9 to 102 nucleotides; it may be folded into an extensive stem-loop structure (3); and it inhibits translation of genes I-V in transiently transfected protoplasts (4, 5).The unusual feature about the CaMV expression strategy is that the CaMV gene VI protein is necessary for efficient translation of genes I-Von the 35S RNA (6-9). Genes I-V, and possibly VI, are believed to be expressed by translation reinitiation; as ribosomes complete the translation of one gene, they reinitiate protein synthesis at the next start codon until all genes are translated (10-12). ...
The double‐stranded DNA of the chlorotic vein banding isolate of peanut chlorotic streak virus (PCISV‐CVB), isolated from purified virus, resolved into circular and linear molecules similar to those of other caulimoviruses. A physical map of viral DNA was constructed, which showed the PCISV‐CVB DNA to be circular and composed of approximately 8·2 kbp. A number of restriction sites were found to be shared with a similar caulimovirus, PCISV, Nevertheless, several differences between physical maps of the two viruses suggest that PCISV‐CVB should be considered as a distinct strain of PCISV. Bam HI‐cleaved PCISV‐CVB DNA was cloned into pUC 118 and was infectious when cleaved from the cloning vector and inoculated onto Vigna unguiculata.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.